The nature of relapse in schizophrenia

R Emsley, B Chiliza, L Asmal, BH Harvey - BMC psychiatry, 2013 - Springer
Background Multiple relapses characterise the course of illness in most patients with
schizophrenia, yet the nature of these episodes has not been extensively researched and …

Update on typical and atypical antipsychotic drugs

HY Meltzer - Annual review of medicine, 2013 - annualreviews.org
Antipsychotic drugs (APDs) are best classified as typical or atypical. The distinction is based
solely on their ability to cause extrapyramidal side effects (EPS), including tardive dyskinesia …

Lurasidone in the treatment of schizophrenia: a randomized, double-blind, placebo-and olanzapine-controlled study

HY Meltzer, J Cucchiaro, R Silva… - American Journal of …, 2011 - Am Psychiatric Assoc
Objective: The study was designed to evaluate the short-term efficacy and safety of
lurasidone in the treatment of acute schizophrenia. Method: Participants, who were recently …

Psychopharmacology of atypical antipsychotic drugs: From the receptor binding profile to neuroprotection and neurogenesis

I Kusumi, S Boku, Y Takahashi - Psychiatry and clinical …, 2015 - Wiley Online Library
The original definition of atypical antipsychotic drugs (APD) was drugs that are effective
against positive symptoms in schizophrenia with no or little extrapyramidal symptoms (EPS) …

Emerging therapeutic opportunities for skeletal restoration

M Kawai, UI Mödder, S Khosla, CJ Rosen - Nature reviews Drug …, 2011 - nature.com
Osteoporosis, a syndrome characterized by thin bones and fractures, has become more
prevalent in both women and men. Established therapies for treating this disorder consist …

Mechanisms of central hypogonadism

TM Barber, I Kyrou, G Kaltsas, AB Grossman… - International Journal of …, 2021 - mdpi.com
Reproductive function depends upon an operational hypothalamo–pituitary–gonadal (HPG)
axis. Due to its role in determining survival versus reproductive strategies, the HPG axis is …

Risk of breast cancer with prolactin elevating antipsychotic drugs: an observational study of US women (ages 18–64 years)

T Rahman, JM Sahrmann, MA Olsen… - Journal of clinical …, 2022 - journals.lww.com
Purpose/Background: Antipsychotic drugs are well established to alter circulating prolactin
levels by blocking dopamine D2 receptors in the pituitary. Prolactin activates many genes …

A neurodevelopment approach for a transitional model of early onset schizophrenia

D De Berardis, S De Filippis, G Masi, S Vicari… - Brain Sciences, 2021 - mdpi.com
In the last decades, the conceptualization of schizophrenia has dramatically changed,
moving from a neurodegenerative process occurring in early adult life to a …

Antipsychotics-induced metabolic alterations: recounting the mechanistic insights, therapeutic targets and pharmacological alternatives

R Singh, Y Bansal, B Medhi, A Kuhad - European journal of pharmacology, 2019 - Elsevier
Atypical antipsychotics (AAPs) are the drug of choice in the management of mental illnesses
by virtue of their advantage over typical antipsychotics ie least tendency of producing …

Lurasidone in the treatment of schizophrenia: a 6-week, placebo-controlled study

M Ogasa, T Kimura, M Nakamura, J Guarino - Psychopharmacology, 2013 - Springer
Rationale There is an unmet need in the treatment of schizophrenia for effective medications
with fewer adverse effects. Objective This study aims to evaluate the efficacy and safety of …